Remedium Retatrutide 50mg Pen is a laboratory-grade peptide formulation developed for scientific investigation into triple-agonist receptor activity and metabolic pathway interaction.
Containing 50mg Retatrutide, this precision peptide pen is commonly examined in laboratory environments for its interaction with GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and glucagon receptor pathways.
Research involving Remedium Retatrutide 50mg Pen frequently focuses on metabolic signalling, receptor-binding dynamics, endocrine pathway behaviour, peptide pharmacology, and energy homeostasis modelling under controlled laboratory conditions.
The precision multi-dose pen system supports consistent measurement throughout structured laboratory protocols, allowing accurate evaluation of peptide stability, receptor interaction, and dose-response characteristics.
This formulation is intended strictly for laboratory and scientific research use.
Key Features
- Premium 50mg Retatrutide peptide formulation
- Precision multi-dose peptide pen
- Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors
- Examined for metabolic and endocrine pathway research
- Laboratory-grade manufacturing standards
- Designed for controlled scientific research applications
Research Applications
Retatrutide research commonly focuses on:
- GLP-1 receptor pathway studies
- GIP receptor signalling research
- Glucagon receptor interaction
- Metabolic pathway investigation
- Endocrine signalling analysis
- Energy homeostasis research
- Peptide-response evaluation
- Receptor-binding modelling
Why Choose Remedium Research?
- Trusted manufacturer of premium peptide formulations
- Precision-engineered peptide pen technology
- High-purity laboratory-grade peptides
- Consistent manufacturing standards
- Designed specifically for scientific investigation
- Widely utilised within controlled research environments
How to Use (Research Reference Only)
This product is intended strictly for laboratory and scientific research conducted under controlled experimental protocols.
Not intended for human consumption.
Package Contents
- 1 × Remedium Retatrutide 50mg Pen
- 20 × Disposable pen needles (31G, 5mm)
- Instruction leaflet
Research Disclaimer
For laboratory and scientific research use only.
Not intended for human consumption, therapeutic use, veterinary application, or medical treatment.
About Retatrutide
Retatrutide is a triple agonist peptide commonly examined within laboratory research for its interaction with GLP-1, GIP, and glucagon receptor pathways. Current scientific investigations focus on metabolic signalling, endocrine regulation, receptor-binding behaviour, peptide pharmacology, and energy homeostasis under controlled laboratory conditions.
Reviews
There are no reviews yet.